Welcome to the HDCRC

Our mission is to provide quality HD care, services, and education to patients, families, and community professionals; to increase awareness of HD in entire communities; and to conduct research contributing to future treatments or cures.

Subscribe to our newsletter now and get:

  • Clinical trial updates
  • HD resource packets
  • Local event information

ScienceDaily News 

  Outline bulletpoint iconCommonalities in brains of people with Huntington's disease and Parkinson's disease1/16/2018
 A new study strongly suggests that the brains of people who have died of Huntington's disease (HD) and Parkinson's disease (PD) show a similar respons...Read More

  Outline bulletpoint iconScheduled feeding improves neurodegenerative symptoms in mice1/16/2018
 Restricting meals to the same time each day improves motor activity and sleep quality in a mouse model of Huntington's disease, according to new resea...Read More

At Risk for HD Blog


  Outline bulletpoint iconIonis scientists provide initial assessment of successful Phase 1/2a Huntington’s disease trial and discuss next steps12/16/2017
 After announcing December 11 that Ionis Pharmaceuticals’ gene-silencing drug for Huntington’s disease safely reduced the production of the toxic HD pr...Read More

  Outline bulletpoint iconIonis drug successfully reduces toxic Huntington’s disease protein, paving way for Phase 2 trial of effect on patients12/11/2017
 In an initial clinical trial that marks a significant step toward finding an effective Huntington’s disease treatment, the Ionis Pharmaceuticals gene-...Read More

  Outline bulletpoint iconA time for hope: HDSA’s 50th anniversary, a record-setting gala, and the impending release of highly anticipated clinical trial results11/10/2017
 This year, Pope Francis’ historic “Hidden No More” audience with the Huntington’s disease community has understandably overshadowed another milestone ...Read More

HDBuzz News


  Outline bulletpoint iconAsk the expert: Q&A on the huntingtin-lowering trial program12/18/2017
 The research news, announced on 11 December 2017, that a research team from the Huntington's Disease Centre at University College London have made...Read More

  Outline bulletpoint iconSuccess! ASO drug reduces levels of mutant protein in Huntington's disease patients12/11/2017
 In an announcement likely to stand as one of the biggest breakthroughs in Huntington's disease since the discovery of the HD gene in 1993, Ionis a...Read More

Our Services 

Medical Services

The GHPP Clinic is staffed by a multidisciplinary team of medical professionals who specialize in the diagnosis and treatment of persons affected with HD. The team includes neurologists, a psychiatrist, clinical nurse specialist, neuropsychologists, a social worker, center coordinator, and dietician. Clinic visits include complementary scheduling for physical therapy, occupational therapy, speech and swallowing evaluations, mobility equipment referrals, and other recurring services.

Family and Caregiver Support

The HDCRC provides services that address issues relating to the care of someone with HD. Assistance may include: general information and referrals, providing education and educational materials, support groups, genetic counseling, placement issues, in-service trainings in care facilities upon request of family member or care facility.

Genetic Testing and Counseling

The HDCRC assists individuals at-risk for inheriting HD, who have made a decision to be tested or are contemplating being tested for the HD gene mutation. Individuals are screened and counseled for issues such as: ability to cope with positive or negative results, relationships with family and friends, insurance planning, marriage and/or family planning, legal issues, career decisions, and support system.

Professional and Community Outreach

The goals of our professional education program are to expose healthcare professionals, police officers, school counselors, social workers, and other community members to a multidisciplinary approach to the care and needs of HD patients, to broaden their perspective, and to make them aware of the problems in caring for patients with HD, which lie outside of their traditional fields. Consultation and educational opportunities are provided to community professionals caring for patients and families affected by HD.

Research

The HDCRC is active in clinical HD research. Participants include those affected with HD, individuals at-risk for HD, family members or friends, and volunteer research subjects. Studies include clinical drug trials, observational trials, neuropsychological studies, and genetic research.

Our Center News 

UCSD Named Center of Excellence

UC San Diego is one of only 29 centers nationwide to receive prestigious designation, which recognizes centers for their elite multidisciplinary approach to Huntington's disease care and research.

Read More

First Laquinimod Patient Enrolled

UC San Diego enrolls the world’s first patient in the LEGATO-HD trial, which explores an investigational multiple sclerosis drug for its potential to improve Huntington’s disease.

Read More

Clinical Trials


Please contact Jody Corey-Bloom, MD, PhD, at (858) 249-0568 or jcoreybloom@ucsd.edu to confirm clinical trial or study availability and/or to get further information about current trials or studies.

Huntington's Disease


 

Our Location


Huntington's Disease Clinical Research Center
at the Shiley-Marcos ADRC
9444 Medical Center Dr., Suite 1-100
La Jolla, CA 92037

Tel: (858) 249-0568
Fax: (858) 249-0573

HDSA Center of Excellence